Literature DB >> 21560190

Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey.

Stéphane Nahon1, Pierre Lahmek, Catherine Saas, Christelle Durance, Alain Olympie, Bruno Lesgourgues, Jean-Pierre Gendre.   

Abstract

BACKGROUND: Adherence to treatment is a key condition in preventing relapses in inflammatory bowel disease (IBD). The aims of this study were specifically to study socioeconomic and psychological factors and adherence to treatment in a large cohort of patients.
METHODS: A questionnaire concerning demographic, clinical, and psychosocial characteristics was mailed to 6000 IBD patients belonging to the French association of IBD patients (AFA). The questionnaire was also available on the Website of the AFA for nonmember patients to answer. Good adherence to treatment was defined as taking ≥ 80% of prescribed medication. Socioeconomic deprivation was assessed using the specific EPICES score (http://www.cetaf.asso.fr) developed in France. Anxiety and depression were assessed using the Hospital Anxiety and Depression scale.
RESULTS: A total of 1069 women and 594 men (43.6 ± 15.4 years) completed the questionnaire; 1450 (87.2%) of them belonged to the AFA. In all, 1044 had Crohn's disease, 36 indeterminate colitis, and 583 ulcerative colitis. Adherence ≥ 80% was reported by 89.6% of patients. Factors associated with good adherence were: older age (P < 0.01), treatment with anti-tumor necrosis factor (TNF) (P < 0.0001), membership in the AFA (P = 0.006). Nonadherence increases with smoking (P = 0.02), constraints related to treatment (P < 10(-9) ), anxiety (P < 10(-6) ), and moodiness (P < 10(-5) ). There were no differences in adherence for the following: gender, type of IBD, activity and severity of the disease, socioeconomic deprivation, marital status, education level, and depression.
CONCLUSIONS: In this large cohort of IBD patients, psychological distress and constraints related to treatment decrease adherence to treatment, while membership in a patients' association improves it.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21560190     DOI: 10.1002/ibd.21482

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  31 in total

Review 1.  Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness.

Authors:  Justin L Sewell; Fernando S Velayos
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

2.  Multiscale analysis of the murine intestine for modeling human diseases.

Authors:  Jesse Lyons; Charles A Herring; Amrita Banerjee; Alan J Simmons; Ken S Lau
Journal:  Integr Biol (Camb)       Date:  2015-07       Impact factor: 2.192

3.  Age Modifies the Association Between Depressive Symptoms and Adherence to Self-Testing With Telemedicine in Patients With Inflammatory Bowel Disease.

Authors:  Kenechukwu Chudy-Onwugaje; Ameer Abutaleb; Andrea Buchwald; Patricia Langenberg; Miguel Regueiro; David A Schwartz; J Kathleen Tracy; Leyla Ghazi; Seema A Patil; Sandra Quezada; Katharine Russman; Sara Horst; Dawn Beaulieu; Charlene Quinn; Guruprasad Jambaulikar; Raymond K Cross
Journal:  Inflamm Bowel Dis       Date:  2018-11-29       Impact factor: 5.325

4.  Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study.

Authors:  Tiago Nunes; Maria Josefina Etchevers; Valle García-Sánchez; Daniel Ginard; Eva Martí; Manuel Barreiro-de Acosta; Fernando Gomollón; Maite Arroyo; Guillermo Bastida; Benito Gonzalez; David Monfort; Esther García-Planella; Carolina Figueroa; Julián Panés; Miquel Sans
Journal:  Am J Gastroenterol       Date:  2016-02-09       Impact factor: 10.864

5.  Assessing quality of life in Crohn's disease: development and validation of the Crohn's Life Impact Questionnaire (CLIQ).

Authors:  Jeanette Wilburn; Stephen P McKenna; James Twiss; Karen Kemp; Simon Campbell
Journal:  Qual Life Res       Date:  2015-02-22       Impact factor: 4.147

6.  Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability.

Authors:  Eric D Shah; Corey A Siegel; Kelly Chong; Gil Y Melmed
Journal:  Dig Dis Sci       Date:  2015-03-14       Impact factor: 3.199

7.  Caregiver-reported neuropsychiatric symptoms in patients undergoing treatment for head and neck cancer: a pilot study.

Authors:  Stewart M Bond; Deborah K Hawkins; Barbara A Murphy
Journal:  Cancer Nurs       Date:  2014 May-Jun       Impact factor: 2.592

8.  Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease.

Authors:  Alexis Calloway; Robin Dalal; Dawn B Beaulieu; Caroline Duley; Kimberly Annis; Lawrence Gaines; Chris Slaughter; David A Schwartz; Sara Horst
Journal:  Dig Dis Sci       Date:  2017-10-20       Impact factor: 3.199

Review 9.  Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: a review.

Authors:  Winfried Häuser; Gabriele Moser; Petra Klose; Antonina Mikocka-Walus
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 10.  Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?

Authors:  C D Moulton; P Pavlidis; C Norton; S Norton; C Pariante; B Hayee; N Powell
Journal:  Clin Exp Immunol       Date:  2019-03-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.